News Remedy Meds buys telehealth rival in $500m marriage Telehealth startup Remedy Meds has expanded its position in the US market at a stroke with a $500m-plus deal to buy Thirty Madison.
News Ro taps Serena Williams as celebrity GLP-1 ambassador The tennis superstar is partnering with the telehealth company to share her story of postpartum weight struggles.
News Noom expands its GLP-1 range with 'microdose' package Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects but remain effective for weight loss.
News Novo Nordisk's fling with Hims & Hers ends in a bust-up The alliance between Novo Nordisk and telehealth firm Hims & Hers for the distribution of GLP-1 agonist weight-loss therapies has ended in acrimony.
News Digital health firm Omada prices $150m IPO In another sign of recovery in digital health investing, Omada Health has priced an IPO that could value the company at more than $1.1 billion.
News Hims & Hers buys Zava to form European beachhead US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe.
News MFN model for Medicaid revealed by CMS The Trump administration has released details of a most-favoured nation (MFN) drug pricing programme for medicines provided by Medicaid.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
